Compounds > cremophor el

Page last updated: 2024-08-24

cremophor el and Neutropenia

cremophor el has been researched along with Neutropenia in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	5 (62.50)	29.6817
2010's	2 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, YH; Huang, ST; Li, WS; Lin, CT; Wang, YP; Wu, HC	1
Harrold, JM; Mager, DE; Mazurchuk, RV; Straubinger, RM; Tamburlin, JH; Zhou, R	1
Keating, GM; Robinson, DM	1
Davidson, N; Harper, P; Harries, M; Ibrahim, N	1
Beijnen, JH; Dubbelman, RC; Hillebrand, MJ; Koopman, FJ; Panday, VR; Rosing, H; Schellens, JH; ten Bokkel Huinink, WW; van Tellingen, O	1
Gianni, L; Henningsson, A; Karlsson, MO; Sparreboom, A; Verweij, J; Viganò, L	1
Behringer, D; Gelderblom, H; Mielke, S; Mross, K; Sparreboom, A; ten Tije, AJ; van Zomeren, DM; Verweij, J	1
Briasoulis, E; Haidou, C; Karavasilis, V; Pavlidis, N; Piperidou, C; Tzamakou, E	1

Trials

3 trial(s) available for cremophor el and Neutropenia

Article	Year
Phase I and pharmacologic study of weekly doxorubicin and 1 h infusional paclitaxel in patients with advanced breast cancer. Anti-cancer drugs, 1998, Volume: 9, Issue:8 Topics: Adult; Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Glycerol; Humans; Infusions, Intravenous; Middle Aged; Neutropenia; Paclitaxel	1998
Mechanism-based pharmacokinetic model for paclitaxel. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Oct-15, Volume: 19, Issue:20 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Doxorubicin; Female; Glycerol; Humans; Infusions, Intravenous; Male; Mathematics; Middle Aged; Neutropenia; Paclitaxel; Solvents	2001
Comparative pharmacokinetics of unbound paclitaxel during 1- and 3-hour infusions. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jan-15, Volume: 20, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; Drug Administration Schedule; Female; Glycerol; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Surface-Active Agents; Thrombocytopenia; Time Factors	2002

Other Studies

5 other study(ies) available for cremophor el and Neutropenia

Article	Year
Liposomal paclitaxel induces fewer hematopoietic and cardiovascular complications than bioequivalent doses of Taxol. International journal of oncology, 2018, Volume: 53, Issue:3 Topics: Animals; Antineoplastic Agents, Phytogenic; Cardiovascular Diseases; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Compounding; Drug Liberation; Drug Screening Assays, Antitumor; Female; Glycerol; Hematologic Diseases; Humans; Liposomes; Male; Mice; Mice, Inbred ICR; Mice, SCID; Neutropenia; Paclitaxel; Therapeutic Equivalency; Tissue Distribution	2018
Differential pharmacodynamic effects of paclitaxel formulations in an intracranial rat brain tumor model. The Journal of pharmacology and experimental therapeutics, 2010, Volume: 332, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; Body Weight; Brain Neoplasms; Chemistry, Pharmaceutical; Disease Models, Animal; Drug Screening Assays, Antitumor; Glycerol; Liposomes; Male; Maximum Tolerated Dose; Models, Theoretical; Neutropenia; Paclitaxel; Pharmaceutical Vehicles; Rats; Rats, Inbred Strains; Tumor Burden	2010
Albumin-bound Paclitaxel: in metastatic breast cancer. Drugs, 2006, Volume: 66, Issue:7 Topics: Albumins; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Female; Glycerol; Humans; Nanostructures; Neoplasm Metastasis; Neutropenia; Paclitaxel; Treatment Outcome	2006
Albumin-bound Paclitaxel in metastatic breast cancer: viewpoints. Drugs, 2006, Volume: 66, Issue:7 Topics: Albumins; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Female; Glycerol; Humans; Nanostructures; Neoplasm Metastasis; Neutropenia; Paclitaxel; Treatment Outcome	2006
Pharmacodynamics of non-break weekly paclitaxel (Taxol) and pharmacokinetics of Cremophor-EL vehicle: results of a dose-escalation study. Anti-cancer drugs, 2002, Volume: 13, Issue:5 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; Dose-Response Relationship, Drug; Female; Glycerol; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Pharmaceutical Vehicles; Surface-Active Agents	2002